Amgen (AMGN) operating income was $10.3B in FY2025 (+39% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2025
$10.3B
+39%
2024
$7.4B
-15%
2023
$8.7B
-9%
2022
$9.6B
+25%
2021
$7.6B
-16%
2020
$9.1B
-6%
2019
$9.7B
-6%
2018
$10.3B
+2%
2017
$10.1B
+2%
2016
$9.8B
+14%
2015
$8.6B
+31%
2014
$6.6B
+12%
2013
$5.9B
+5%
2012
$5.6B
+29%
2011
$4.3B
-22%
2010
$5.5B
+0%
2009
$5.5B
+4%
2008
$5.3B
+33%
2007
$4.0B
Recent Quarterly Operating Income
Quarter
Operating Income
Q1 2026
$2.7B
Q4 2025
$2.7B
Q3 2025
$2.9B
Q2 2025
$2.7B
Q1 2025
$2.0B
Q4 2024
$2.3B
Q3 2024
$2.1B
Q2 2024
$1.9B
Q1 2024
$1.1B
Q4 2023
$1.9B
Q3 2023
$2.1B
Q2 2023
$2.7B
Source: AMGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.